Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent and Superpotent Drug
| Brand name | LEVOTHYROXINE SODIUM |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA |
| NDC | 51079-442-20 |
| Full product label | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20 |
| Recalling firm | Mylan Institutional, Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 2,835 cartons |
| Recall initiated | 2024-11-19 |
| Report date | 2024-12-18 |
| Recall completed | — |
| Recall number | D-0131-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Rockford IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗